Investing in people
Lux Capital invests in emerging science and technology ventures at the outermost edges of what is possible.
We partner with iconoclastic inventors challenging the status quo and the laws of nature to bring their futuristic ideas to life.
Play Video Discover LUXOur Companies
Want to know what the future will look like? Spend some time with our companies. You might meet a genetic engineer programming matter at the molecular level; a biologist and electrical engineer designing a new surgical robot; an astrophysicist launching rockets into space; or a materials scientist making circuits using a technique lifted from once-classified government programs.
-
Auris HealthAuris Health is an ambitious robotics company based in Silicon Valley. Auris was acquired by Johnson & Johnson in 2019.
-
CTRL-labs
CTRL-labs is changing the way we interact with computers. CTRL-labs was acquired by Facebook in 2019.
-
Desktop Metal
Desktop Metal is bringing high-speed, high-performance, 3D metal printing to the office environment.
-
Drone Racing League
Drone Racing League is a sports, media and technology company that combines world-class pilots, iconic locations, and proprietary technology to create engaging drone races with mass appeal.
-
Matterport
Matterport is the world’s most powerful all-in-one 3D data platform lets you turn a space into an accurate and immersive digital twin.
-
Recursion Pharmaceuticals
Recursion Pharma is combining high-throughput experimental biology, bioinformatics, and machine learning to rapidly identify new indications for many known drugs and shelved assets.
-
Saildrone
Saildrone collects valuable ocean data using a fleet of unmanned, autonomous sailing drones.
-
Zoox
Zoox is what comes after the automobile. The company was acquired by Amazon in 2020.
Our team is willing to take a chance on something other investors do not see.
We are neuroscientists, chemists, data scientists, computational biologists, economists, electrical engineers, machine-learning hackers and philosophers. We get fired up when audacious experimentation leads to heresy and reinvention.
News & Insights
At-Home Health Testing Company Everlywell Raises $175 Million Series D Round At A $1.3 Billion Valuation
Leah Rosenbaum-
November 24, 2020
Braid Health granted FDA clearance for AI-powered diagnostic collaboration platform
-
November 24, 2020
Medicines Based on Unusual Traits: Andrew Farnum
-
November 24, 2020
FDA Authorizes Regeneron Treatment Enabled By Science 37
-
November 23, 2020
Biotech VC Bob Nelsen called it right on the coronavirus. Now he has thoughts on therapeutics
-
November 23, 2020
Resilience Launches to Change the Future of Medicine through Manufacturing Innovation